CASTLEVAX Wins $398,973,027 Federal Contract
Copyright © Targeted News Service 2023
2023-09-29
WASHINGTON, Sept. 29 -- CASTLEVAXNew York won a federal contract award for $398,973,027 from the Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response for research and development in biotechnology (except nanobiotechnology). The document states about the contract: phase 2b clinical trial to develop a next-generation, mucosally delivered, covid-19 booster vaccine capable of eliciting mucosal immunity and protecting against sars-cov-2 breakthrough infe . . .
Contact: Kathleen Sears
Targeted News Service Information Request Form
Contact: Kathleen Sears
